Palisade Bio Statistics
Share Statistics
Palisade Bio has 4.8M
shares outstanding. The number of shares has increased by 369.53%
in one year.
| Shares Outstanding | 4.8M |
| Shares Change (YoY) | 369.53% |
| Shares Change (QoQ) | 58.95% |
| Owned by Institutions (%) | 17.25% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 272 |
| FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 40.93K, so 0.89% of the outstanding
shares have been sold short.
| Short Interest | 40.93K |
| Short % of Shares Out | 0.89% |
| Short % of Float | 0.94% |
| Short Ratio (days to cover) | 1.14 |
Valuation Ratios
The PE ratio is -0.16 and the forward
PE ratio is -0.55.
Palisade Bio's PEG ratio is
0.
| PE Ratio | -0.16 |
| Forward PE | -0.55 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.31 |
| P/FCF Ratio | -0.19 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Palisade Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.24,
with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.24 |
| Quick Ratio | 3.24 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,804,750 |
| Employee Count | 8 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -89.47% in the
last 52 weeks. The beta is 1.33, so Palisade Bio's
price volatility has been higher than the market average.
| Beta | 1.33 |
| 52-Week Price Change | -89.47% |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 2.11 |
| Relative Strength Index (RSI) | 39.44 |
| Average Volume (20 Days) | 377,306 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.86M |
| Net Income | -14.44M |
| EBITDA | -14.86M |
| EBIT | -14.45M |
| Earnings Per Share (EPS) | -10.19 |
Full Income StatementBalance Sheet
The company has 9.82M in cash and 169K in
debt, giving a net cash position of 9.65M.
| Cash & Cash Equivalents | 9.82M |
| Total Debt | 169K |
| Net Cash | 9.65M |
| Retained Earnings | -135.94M |
| Total Assets | 10.88M |
| Working Capital | 7.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -12.19M
and capital expenditures 0, giving a free cash flow of -12.19M.
| Operating Cash Flow | -12.19M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.19M |
| FCF Per Share | -8.61 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
